CDMO Emergent, partner to three COVID-19 vaccine developers, gets $628M BARDA task order

HHS has agreed to award Emergent BioSolutions with up to $628 million to provide manufacturing services to COVID-19 vaccine developers with whom it has partnered, expanding an existing contract between Emergent and the department's Biomedical Advanced Research and Development Authority.

The award is part of Operation Warp Speed, the U.S. government's initiative to speed development of interventions for the novel coronavirus...